INTERNATIONAL CONGRESS OF
CancerGenetics
Personalized medicine in cancer Panel
2025/10/23
08:00-08:30 | Wellcome Massage of the Chairman of Cancer Genetics Congress
Prof. Mohammad Reza Noori Daloii |
Speaker
Position of Speaker
Distinguished Professor of Medical Genetics. Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Contact
Email: Prof.MohammadRezaNooriDaloii [at] icgcongress [dot] com
08:30-08:45 | Wellcome Message Of The Chairman Of The Personalized Medicine in Cancer Panel
Dr. Reza Shirkoohi |
Chairman
Position of Speaker
Cancer Biology Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
Contact
Email: RezaShirkoohi [at] icgcongress [dot] com
08:45-09:15 | Personalized Medicine In Cancer. Past . Present And Future. An Expeience From Cancer Institute Of Iran
Dr. Reza Shirkoohi |
Speaker
Position of Speaker
Cancer Biology Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
Contact
Email: RezaShirkoohi [at] icgcongress [dot] com
09:15-09:45 | Application Of Tumor Molecular Profiling In Diagnosis And Treatments Of Gynecological Cancers
Dr. Gholamreza Rafiei |
Speaker
Position of Speaker
Genome medical genetics laboratory Director
Contact
Email: GholamrezaRafiei [at] icgcongress [dot] com
09:45-10:15 | From Variants To Decisions : AI-Driven Interpretation In Precision Medicine
Dr. Farideh Ghanbari Mardasi |
Speaker
Position of Speaker
Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Contact
Email: FaridehGhanbariMardasi [at] icgcongress [dot] com
10:15-10:45 | The Role Of Circulating Tumor Cells In Precision Oncology
Dr. Mohammad Reza Eskandarion |
Speaker
Position of Speaker
Cancer Research Center, Cancer Institute, IKHC, Tehran University of Medical Sciences, Tehran, Iran
Contact
Email: MohammadRezaEskandarion [at] icgcongress [dot] com
10:45-11:15 | Precision Medicine In Breast Cancer
Dr. Keivan Majidzadeh |
Speaker
Position of Speaker
Cancer Genetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR
Contact
Email: KeivanMajidzadeh [at] icgcongress [dot] com
The role of the microbiome in cancer Panel
2025/10/23
11:15-11:45 | Gut Microbiome in Neuro-Oncology: Emerging Roles in Glioma Progression and Therapeutic Prospects
Dr. Mohammad Saremi |
Speaker
Position of Speaker
Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Contact
Email: MohammadSaremi [at] icgcongress [dot] com
11:45-12:15 | H. pylori & Microbiome interaction in Gastric Cancer
Dr. Sara Kadkhodaei |
Speaker
Position of Speaker
Contact
Email: SaraKadkhodaei [at] icgcongress [dot] com
Personalized Medicine in the Treatment of Ocular Surface Squamous Neoplasia (OSSN) Panel
2025/10/24
08:00-08:15 | Wellcome Message Of The Chairman Of The Personalized Medicine in the Treatment of Ocular Surface Squamous Neoplasia (OSSN) Panel
Dr. Zohreh Salatanatpouri |
Chairman
Position of Speaker
Contact
Email: ZohrehSalatanatpouri [at] icgcongress [dot] com
08:15-08:45 | Plasma-Drived Regenerative Medicine Focused Personalized Products In Wound Treatments After Cancer Surgery And Radiotherapy
Dr. Hamidreza Rahimi |
Speaker
Position of Speaker
Contact
Email: HamidrezaRahimi [at] icgcongress [dot] com
08:45-09:15 | Methylation-Based Personalized Medicine In Human Cancer
Dr. Fatemeh Khatami |
Speaker
Position of Speaker
Contact
Email: FatemehKhatami [at] icgcongress [dot] com
09:15-09:45 | Reprogramming the Tumor Battlefield: A Triple-Hit Immunoepigenetic Strategy Against Tumor Resistance”
Dr. Mohammadali Zolfaghari |
Speaker
Position of Speaker
Contact
Email: MohammadaliZolfaghari [at] icgcongress [dot] com
09:45-10:15 | Application of percision Medicine In Biomarker Prediction For Diabetic Breast Cancer Patients
Dr. Yasaman Naeimzadeh |
Speaker
Position of Speaker
Contact
Email: YasamanNaeimzadeh [at] icgcongress [dot] com
10:15-10:45 | Isolation And Characterization Of Amniotic Fluid Stem Cells And Its Anti Tumor Effect Application On Ovarian Cancer Cell Line
Dr. Shiva Gholizadeh |
Speaker
Position of Speaker
Contact
Email: ShivaGholizadeh [at] icgcongress [dot] com
Carcinogenic Viruses Panel
2025/10/24
10:45-11:00 | Wellcome Message Of The Chairman Of The Carcinogenic Viruses Panel
Dr. Seyed Reza Mohebbi |
Chairman
Position of Speaker
Contact
Email: SeyedRezaMohebbi [at] icgcongress [dot] com
11:00-11:30 | Viral Hepatitis and Liver Cancer ; Reviewing Molecular Mechanisms Of Hepatocarcinogenesis and Novel Treatments
Dr. Seyed Reza Mohebbi |
Speaker
Position of Speaker
Contact
Email: SeyedRezaMohebbi [at] icgcongress [dot] com
11:30-12:00 | How Oncoviruses Evade Host Immunity to Promote Carcinogenesis
Dr. Shahrzad Shoraka |
Speaker
Position of Speaker
Contact
Email: ShahrzadShoraka [at] icgcongress [dot] com
12:00-12:30 | Reawakening Ancient Viruses : The Role Of HERVs In Tumor Oncogenesis
Dr. Rahim Soleimani Jelodar |
Speaker
Position of Speaker
Contact
Email: RahimSoleimaniJelodar [at] icgcongress [dot] com
Metabolic Interactions in Cancer Panel
2025/10/25
08:00-08:15 | Wellcome Message Of The Chairman Of The Metabolic Interactions in Cancer Panel
Prof. Dariush Norouzian |
Chairman
Position of Speaker
Contact
Email: Prof.DariushNorouzian [at] icgcongress [dot] com
08:00-08:30 | Gas Chromatography-Mass Spectrometry-Based Uuntargeted Metabolomics Reveals Metabolic Perturbations In Medullary Thyroid Carcinoma
Dr. Morteza Ghazanfari |
Speaker
Position of Speaker
pasteur institute of Iran
Contact
Email: MortezaGhazanfari [at] icgcongress [dot] com
08:30-09:00 |
Dr. Saman Aminzadeh |
Speaker
Position of Speaker
A.Metabolomics Lab, Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran B.Department of Immunology, Pasteur Institute of Iran,Tehran, Iran
Contact
Email: SamanAminzadeh [at] icgcongress [dot] com
Genomic Variations and Cancer Management Panel
2025/10/25
09:00-09:15 | Wellcome Message Of The Chairman Of The Genomic Variations and Cancer Management Panel
Dr. Mohammadamin Tabatabaeifar |
Chairman
Position of Speaker
Position: -Professor of Medical Genetics, Department of Genetics, Isfahan University of Medical Sciences, Isfahan, Iran - The coordinator of the Harmonic Lab Network, Iran - The member of the Board of Directors, Iranian Society of Medical Genetics
Contact
Email: MohammadaminTabatabaeifar [at] icgcongress [dot] com
09:15-09:45 | The Role Of Genetic Variants In The Management Of Lynch Syndrome
Dr. Mehrdad Zeinalian |
Speaker
Position of Speaker
Isfahan University of Medical Sciences
Contact
Email: MehrdadZeinalian [at] icgcongress [dot] com
09:45-10:15 | Interaction Of HPV Infection with The Human Variome : Lessons From Epidermodysplasia Verruciformis
Dr. Sajjad Biglari |
Speaker
Position of Speaker
Farin Genetics Laboratory, Tehran, Iran
Contact
Email: SajjadBiglari [at] icgcongress [dot] com
10:15-10:45 | The Emerging Role of AI In The Management Of Cancer : Focus On Variant Data Interpretation And Integration
Dr. Mohammadamin Tabatabaeifar |
Speaker
Position of Speaker
Professor of Medical Genetics, Department of Genetics, Isfahan University of Medical Sciences, Isfahan, Iran -The coordinator of the Harmonic Lab Network, Iran - The member of the Board of Directors, Iranian Society of Medical Genetics
Contact
Email: MohammadaminTabatabaeifar [at] icgcongress [dot] com
10:45-11:15 | Hereditary Polyposis Syndromes
Dr. Massih Bahar |
Speaker
Position of Speaker
Familial and Hereditary Cancers Institute
Contact
Email: MassihBahar [at] icgcongress [dot] com
11:15-11:45 | Liquid Biopsy Followed By Variant Identification : Emerging Role In Cancer Management
Dr. Mohammad Mehdi Jahani |
Speaker
Position of Speaker
Lab director of Harmonic Medical Genetics and Pathobiology Laboratory
Contact
Email: MohammadMehdiJahani [at] icgcongress [dot] com
11:45-12:15 | The Role Of Genetic Variants In Response And Resistance To Novel Cellular Therapies : From Leukemia Genomics To The Optimization Of CAR-T Therapy
Dr. Majid Mojarrad |
Speaker
Position of Speaker
-Associate professor of Medical Genetics,MUMS -Head of Genetic Foundation of khorasan Razavi -CEO of Simbiolab Company
Contact
Email: MajidMojarrad [at] icgcongress [dot] com
Oral presentations
A Network Pharmacology Investigation into the Multi-Target Mechanisms of Withalongolide A Against Pancreatic Cancer
Panel: Bioinformatics in Cancer
Advancements of Adenovirus-Based Gene Therapy in Colorectal Cancer
Panel: Personalized medicine in cancer
Artificial Intelligence-Based Epigenetic Models for Predicting Hereditary Cancer Susceptibility
Panel: Personalized Medicine in the Treatment of Ocular Surface Squamous Neoplasia (OSSN)
Cancer Incidence and Mortality in Different Populations: The Role of Genetic Ancestry
Panel: Genomic Variations and Cancer Management
Clinical Relevance of CYP3A4 Polymorphisms rs2242480 and rs55951658 as Predictive Biomarkers in Breast Cancer Risk Assessment
Panel: Genomic Variations and Cancer Management
Comprehensive Review and Meta-Analysis of Next-Generation Sequencing Applications in Lung Cancer: Focus on Mutation Identification
Panel: Bioinformatics in Cancer
Discovery of Lung Cancer Biomarkers via Bioinformatics: Focus on the CAV1 Gene
Panel: Bioinformatics in Cancer
Dual-Target CAR-T Cell Strategies for Glioblastoma: Overcoming Antigen Heterogeneity and Microenvironmental Barriers
Panel: Personalized medicine in cancer
Effects of Anticancer Activity of Interferon Gamma on Colon Cancer Cell Lines: based on Network Pharmacology Analysis
Panel: Bioinformatics in Cancer
Epigenetics in Breast Cancer: From Molecular Mechanisms to Novel Therapeutic Approaches
Panel: Personalized Medicine in the Treatment of Ocular Surface Squamous Neoplasia (OSSN)
Evaluation of Common Polymorphisms in Brain Cancer and Assessment of Adverse Effects of Anticancer Drugs
Panel: Bioinformatics in Cancer
From Bench to Bedside: The Clinical Translation Gap in Cancer Nanomedicine
Panel: Metabolic Interactions in Cancer
From Liquid Biopsy to Therapy: The Rising Role of Circulating Tumor Cell Clusters in Cancer Progression
Panel: Metabolic Interactions in Cancer
Global and Regional DNA methylation of MMP2 and expression of DNA Methyltransferase in gastric adenocarcinoma
Panel: Personalized Medicine in the Treatment of Ocular Surface Squamous Neoplasia (OSSN)
Gut Microbiome Influence on Gliomas and Their Impact on Tumor Immunity and Therapy
Panel: The role of the microbiome in cancer
Harnessing Oncolytic Viruses for Targeted Treatment of Triple-Negative Breast Cancer: Promises and Challenges
Panel: The role of the microbiome in cancer
Hub microRNAs as Master Regulators in a Saffron-Targeted Breast Cancer Network
Panel: Bioinformatics in Cancer
Integrated Bioinformatics Analysis Identifies CDCA7 and DLGAP5 as Key Genes with NEAT1-Mediated lncRNA Regulation in Chronic-Phase CML
Panel: Bioinformatics in Cancer
Integrative Bioinformatics Analysis Identifies FYN and Its lncRNA–miRNA Network as Prognostic Biomarkers in Acute Myeloid Leukemia
Panel: Bioinformatics in Cancer
Integrative Multi-Omics Analysis for Personalized Cancer Therapy Combining genomics, proteomics, and metabolomics data from CPTAC or TARGET to design individualized treatments. - Bioinformatic A...
Panel: Metabolic Interactions in Cancer
Investigating hsa-miR-193-3p and hsa-let-7e-3p and Their Target Genes IGFBP5 and AGPAT5 Associated with Fusobacterium nucleatum in Patients with Colorectal Polyps and CRC: In Silico Predictions and Experimental Validation
Panel: The role of the microbiome in cancer
Investigation of Common Genetic Variants Involved in Breast Cancer and the Interacting Roles of MicroRNAs and Obesity in Disease Pathogenesis
Panel: Personalized Medicine in the Treatment of Ocular Surface Squamous Neoplasia (OSSN)
Investigation of somatic mutations and polymorphisms of the KRAS and NRAS genes in colorectal cancer.'
Panel: Genomic Variations and Cancer Management
Leveraging tumor microenvironment metabolism for smart drug delivery systems
Panel: Metabolic Interactions in Cancer
Multiscale Bioinformatic Modeling for CRISPR-Based Immune Cell Engineering: A Framework for Targeted Cancer Immunotherapy
Panel: Personalized medicine in cancer
Physiological Alterations and Gene Regulation in the Tumor Microenvironment
Panel: Personalized Medicine in the Treatment of Ocular Surface Squamous Neoplasia (OSSN)
Role of Counseling and Psychological Support in Improving Fertility among Cancer Patients: A Review Study
Panel: Genomic Variations and Cancer Management
Saffron Bioactives as Adjuvant Modulators of Breast-Cancer microRNA Networks
Panel: Personalized Medicine in the Treatment of Ocular Surface Squamous Neoplasia (OSSN)
Systems Biology Approach Reveals ESR1 and CDK1 Regulatory Axis with miRNA–lncRNA Network as Novel Biomarkers in Uterine Corpus Endometrial Carcinoma
Panel: Bioinformatics in Cancer
The interaction of lncRNA and mRNA in Esophageal Squamous Cell Carcinoma
Panel: Bioinformatics in Cancer
The microbiome and its role in the development of breast cancer
Panel: The role of the microbiome in cancer
The Oncobiome in Precision Cancer Care: Microbiome-Guided Diet and Personalized Therapeutics
Panel: The role of the microbiome in cancer
The Role of the Microbiome in Cancer Prevention and Therapy
Panel: The role of the microbiome in cancer
The Tumor Microenvironment and Immunotherapy Response: Challenges and Opportunities in Precision Oncology
Panel: Personalized medicine in cancer
The utility of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in the early detection of postsurgical bacterial meningitis: A retrospective analysis
Panel: The role of the microbiome in cancer
Title: High-grade leiomyosarcoma with constitutional homozygous PTEN p.Pro95Arg and tumor APC/NBN VUS on paired WES
Panel: Genomic Variations and Cancer Management
Unlocking Nature's Arsenal: The Expanding Therapeutic Role of Berberine in Combating Lung Cancer
Panel: Personalized Medicine in the Treatment of Ocular Surface Squamous Neoplasia (OSSN)
Unveiling Molecular Mechanisms and Biomarkers for Colitis-Associated Colorectal Cancer in Ulcerative Colitis
Panel: Bioinformatics in Cancer
Poster presentations
A Focused Review of Bioinformatics Pipelines for Circulating Tumor DNA (ctDNA) Analysis
Panel: Bioinformatics in Cancer
A Review of Genetic and Epigenetic Alterations Underlying Hereditary and Sporadic Cancer Susceptibility
Panel: Bioinformatics in Cancer
A Review on the Design of Revolutionary Synthetic Gene Circuits for Precision Gene Editing in Oncology and Cellular Reprogramming
Panel: Bioinformatics in Cancer
Advancements of Adenovirus-Based Gene Therapy in Colorectal Cancer
Panel: Bioinformatics in Cancer
Aerobic Glycolysis Gene Overexpression and Prognostic Value in Pancreatic Ductal Adenocarcinoma: A Systematic Review
Panel: Bioinformatics in Cancer
AKT1 as a central hub gene in miR-424/503 cluster-regulated oncogenic networks in cervical cancer
Panel: Bioinformatics in Cancer
An Exploratory Transcriptomic Analysis of Granulosa Cells in Normal-Weight PCOS Women Suggests Altered DNA Repair and Signaling Pathways Linked to Cancer Risk
Panel: Bioinformatics in Cancer
Application of bioinformatics tools for the detection of germline BRCA1/BRCA2 variants in diagnostic NGS data: A Systematic Review
Panel: Bioinformatics in Cancer
Application of Gene Editing Technologies in the Treatment of Colorectal Cancer: A Novel Approach in Personalized Medicine
Panel: Bioinformatics in Cancer
Artificial Intelligence-Based Epigenetic Models for Predicting Hereditary Cancer Susceptibility
Panel: Bioinformatics in Cancer
Association Between Fluoroquinolone Antibiotic Exposure and Breast Cancer Risk or Progression: A Systematic Review
Panel: Bioinformatics in Cancer
Base Editing Approaches for Correcting TP53 and KRAS Mutations in Colorectal Cancer: A Systematic Review
Panel: Bioinformatics in Cancer
Bioinformatics Analysis Identifies Shared lncRNAs Associated with CDH5 and PTPRB in the Adherens Junction Pathway of Lung Adenocarcinoma
Panel: Bioinformatics in Cancer
Bioinformatics in Oncology: Tools, Challenges, and Clinical Applications
Panel: Bioinformatics in Cancer
BRCA 1/2 mutation and incidence of skin cancers: A Systematic Review and Meta-Analysis
Panel: Bioinformatics in Cancer
Breast cancer metastasis development and the role of oncobiosis and bacterial metabolite signaling
Panel: Bioinformatics in Cancer
Chitosan-Functionalized Niosomes as a Dual-Action Delivery System for Spirulina maxima: Targeting Drug-Resistant Bacteria and Colorectal Cancer Cells
Panel: Bioinformatics in Cancer
Clinical Relevance of CYP3A4 Polymorphisms rs2242480 and rs55951658 as Predictive Biomarkers in Breast Cancer Risk Assessment
Panel: Bioinformatics in Cancer
Comprehensive Bioinformatics Analysis Identifies INHBA and Its lncRNA Network as Key Drivers of Colorectal Cancer
Panel: Bioinformatics in Cancer
Comprehensive Review and Meta-Analysis of Next-Generation Sequencing Applications in Lung Cancer: Focus on Mutation Identification
Panel: Bioinformatics in Cancer
CRISPR Models for Gene Knockout in Transcription-Coupled Repair and DNA-Protein Crosslink Outcomes in Lymphoid Leukemia
Panel: Bioinformatics in Cancer
CRISPR-miRNA Synergy: Editing Tumor Suppressor miRNAs into Oncogenic "Dead Zones"
Panel: Bioinformatics in Cancer
Design and Computational Analysis of CRISPR-Based Base Editors: Predicting Efficiency and Protein Stability for Precision Gene Editing
Panel: Bioinformatics in Cancer
Dietary Fiber and Gut Microbiota in Colorectal Cancer: A Narrative Review
Panel: Bioinformatics in Cancer
Dual Targeting of CD73/EGFR Axis via siRNA Nanocarriers: A Novel Immunotherapeutic Strategy Against Breast Cancer
Panel: Bioinformatics in Cancer
Dual-Target CAR-T Cell Strategies for Glioblastoma: Overcoming Antigen Heterogeneity and Microenvironmental Barriers
Panel: Bioinformatics in Cancer
Effects of Anticancer Activity of Interferon Gamma on Colon Cancer Cell Lines: based on Network Pharmacology Analysis
Panel: Bioinformatics in Cancer
Engineered exosomes in cancer gene therapy
Panel: Bioinformatics in Cancer
Engineering and Production of a Recombinant HER3-Binding Affibody-EGFP Fusion Protein as a Potential Diagnostic Probe for Cancer Research
Panel: Bioinformatics in Cancer
Engineering the Gut Microbiome for Targeted Cancer Therapies
Panel: Bioinformatics in Cancer
Epigenetic Alterations in Hereditary Cancers: Diagnostic, Prognostic, and Therapeutic Insights
Panel: Bioinformatics in Cancer
Epigenetic Alterations in Hereditary Cancers: Implications for Precision Oncology
Panel: Bioinformatics in Cancer
Epigenetic Alterations in Hereditary Cancers: Mechanisms, Biomarkers, and Therapeutic Advances
Panel: Bioinformatics in Cancer
Epigenetic Alterations in Lymphoid Leukemia: The Role of DNA Methylation, Histone Modifications, and lncRNAs
Panel: Bioinformatics in Cancer
Epigenetic Links Between Chronic Stress, Emotional Regulation, and Molecular Pathways in Hereditary Breast Cancer: Novel Perspectives for Therapy and Prevention
Panel: Bioinformatics in Cancer
Epigenetic Reactivation of Fetal Hemoglobin in Leukemia: A Mechanism of Clonal Advantage
Panel: Bioinformatics in Cancer
Epigenetic Regulation and Therapeutic Implications in Hereditary Cancers
Panel: Bioinformatics in Cancer
Epigenetic Regulation of EBV Reactivation in Immunocompromised Patients
Panel: Bioinformatics in Cancer
Epigenetic Therapies Against Virus-Driven Cancers: A New Frontier
Panel: Bioinformatics in Cancer
Epigenetics in Breast Cancer: From Molecular Mechanisms to Novel Therapeutic Approaches
Panel: Bioinformatics in Cancer
EV-Mediated Immune Modulation in Tumor Microenvironment
Panel: Bioinformatics in Cancer
Evaluation of Common Polymorphisms in Brain Cancer and Assessment of Adverse Effects of Anticancer Drugs
Panel: Bioinformatics in Cancer
Evaluation of miR-98-5P and GAB2 gene expression in endometriosis
Panel: Bioinformatics in Cancer
Exosomal microRNAs as a therapeutic approach in breast cancer: A review
Panel: Bioinformatics in Cancer
Exploring the Role of TRIB3 in Temozolomide Resistance of Glioblastoma through a ceRNA Regulatory Network Analysis
Panel: Bioinformatics in Cancer
Expression investigation of PD-1, an immune system inhibitory marker, in tumor tissue of bladder cancer patients
Panel: Bioinformatics in Cancer
Expression of lncRNAs DLEU1 and DLEU2 in Ovarian Cancer and Their Association with Clinicopathological Features
Panel: Bioinformatics in Cancer
Fecal extracellular vesicles as emerging mediators in microbiome–host communication and cancer metabolomics: a comprehensive review
Panel: Bioinformatics in Cancer
Feline Mammary Carcinoma – Challenges and Advances in Veterinary Oncology
Panel: Bioinformatics in Cancer
From Bench to Bedside: The Clinical Translation Gap in Cancer Nanomedicine
Panel: Bioinformatics in Cancer
From In Vitro Modeling to Clinical Applications: The Role of 3D Printing in Prostate Cancer Treatment
Panel: Bioinformatics in Cancer
Genetic Alterations in K-RAS, N-RAS, and BRAF Oncogenes in Metastatic Colorectal Cancer: A Frequency Analysis
Panel: Bioinformatics in Cancer
Genomic comparison of feline and human mammary tumors: new insights for cancer modeling.
Panel: Bioinformatics in Cancer
Genomic interventions in oncology: Emerging Strategies to Address Cancer Therapy Limitations
Panel: Bioinformatics in Cancer
Genomic profiling of TMX2 reveals functional variants driving Gliobblastoma
Panel: Bioinformatics in Cancer
Germline Polymorphisms in Chromatin Regulatory Genes Modulate Gut Microbiome and Colorectal Cancer Risk
Panel: Bioinformatics in Cancer
GLS1 Inhibition and Glutamine Addiction in MYC-Driven Burkitt Lymphoma: A Systematic Review
Panel: Bioinformatics in Cancer
Harnessing Oncolytic Viruses for Targeted Treatment of Triple-Negative Breast Cancer: Promises and Challenges
Panel: Bioinformatics in Cancer
Helicobacter pylori and the Role of the Gastric Bacterial Microbiome in Gastric Cancer
Panel: Bioinformatics in Cancer
Histone Dysregulation and Hereditary Cancer Syndromes
Panel: Bioinformatics in Cancer
Identification of Molecular Targets for Gene Therapy in Canine Mammary Tumors Through Integrative Gene Network Analysis
Panel: Bioinformatics in Cancer
Identification of Stage-Specific Genes in Cervical Cancer Using Bioinformatics Tools
Panel: Bioinformatics in Cancer
Immune-Related Genetic Polymorphisms as Predictors of Checkpoint Inhibitor Response in Solid Tumors
Panel: Bioinformatics in Cancer
Impact of Host Genome and Microbiome on Cancer Immunotherapy Response
Panel: Bioinformatics in Cancer
Impact of Lipid Metabolism Reprogramming on Drug Resistance in Breast Cancer: A Systematic Review
Panel: Bioinformatics in Cancer
Integrated Bioinformatics Analysis Identifies CDCA7 and DLGAP5 as Key Genes with NEAT1-Mediated lncRNA Regulation in Chronic-Phase CML
Panel: Bioinformatics in Cancer
Integrating AI/ML and Multi-Omics Approaches in Pancreatic Cancer Research
Panel: Bioinformatics in Cancer
Integration of Systemic Metabolism and Immune Regulation: New Frontiers in Cancer Prevention and Therapy
Panel: Bioinformatics in Cancer
Integrative Bioinformatics Analysis Identifies FYN and Its lncRNA–miRNA Network as Prognostic Biomarkers in Acute Myeloid Leukemia
Panel: Bioinformatics in Cancer
Integrative Multi-Omics Analysis for Personalized Cancer Therapy Combining genomics, proteomics, and metabolomics data from CPTAC or TARGET to design individualized treatments. - Bioinformatic A...
Panel: Bioinformatics in Cancer
Investigating hsa-miR-193-3p and hsa-let-7e-3p and Their Target Genes IGFBP5 and AGPAT5 Associated with Fusobacterium nucleatum in Patients with Colorectal Polyps and CRC: In Silico Predictions and Experimental Validation
Panel: Bioinformatics in Cancer
Investigating the effect of aqueous extract of Centella asiatica plant on the expression of Bax and Bcl-2 genes in rat lung tissue during the process of cancer induction
Panel: Bioinformatics in Cancer
Investigating the interaction between the WNT2 gene as a potential biomarker and its associated miRNA in colorectal cancer through bioinformatics analysis
Panel: Bioinformatics in Cancer
Investigating the Role of the Gut Microbiome in the Response to Melanoma Immunotherapy
Panel: Bioinformatics in Cancer
Investigation of the Association Between HLA (HLA-A, B, DRB1) Alleles and Susceptibility to Acute Lymphoblastic Leukemia in Southern Iran
Panel: Bioinformatics in Cancer
Lactate Dehydrogenase A Overexpression and Tumor Microenvironment Acidosis in Triple-Negative Breast Cancer: A Systematic Review
Panel: Bioinformatics in Cancer
LAT1 Amino Acid Transporter Overexpression and Tumor Growth in Glioblastoma: A Systematic Review
Panel: Bioinformatics in Cancer
Leveraging tumor microenvironment metabolism for smart drug delivery systems
Panel: Bioinformatics in Cancer
Merkel Cell Polyomavirus Large T-Antigen Mutations in Merkel Cell Carcinoma Pathogenesis: A Systematic Review
Panel: Bioinformatics in Cancer
Meta-Analysis on Gene Expression: the Therapeutic Efficacy of Inulin in Caco-2 Cancer Cells
Panel: Bioinformatics in Cancer
Metabolic Interactions in Cancer: A Contemporary Review of TME Crosstalk and Therapeutic Insights
Panel: Bioinformatics in Cancer
Molecular advances in the detection and management of the most common cancer among women over the past three years
Panel: Bioinformatics in Cancer
Municipal Landscape-Derived Echinacea purpurea: A Green Nano-Biotechnological Approach for Enhanced Anticancer Compound Production
Panel: Bioinformatics in Cancer
Network-Based Identification of Molecular Drivers and Therapeutic Targets in Canine Osteosarcoma
Panel: Bioinformatics in Cancer
Next-Generation Cancer Vaccines: mRNA Platforms and Personalized Neoantigen Approaches
Panel: Bioinformatics in Cancer
Oncolytic Herpes Simplex Virus Therapy for Glioblastoma: A Systematic Review of Clinical Outcomes and Immunological Effects
Panel: Bioinformatics in Cancer
Oral Microbiome–Driven Inflammatory Pathways in Head and Neck Squamous Cell Carcinoma: A Systematic Review
Panel: Bioinformatics in Cancer
Physiological Alterations and Gene Regulation in the Tumor Microenvironment
Panel: Bioinformatics in Cancer
Polymorphisms in Tumor Suppressor Genes (TP53, BRCA1/2) and Cancer Risk Modulation
Panel: Bioinformatics in Cancer
Precision CRISPR-Cas9 Targeting of PD-1 in T Cells for Enhanced Immunotherapeutic Response in Solid Tumors : A Systematic Review
Panel: Bioinformatics in Cancer
Progress in Hepatocellular Carcinoma: Transitioning from Molecular Diagnostics to Targeted Treatments and Genomic Insights
Panel: Bioinformatics in Cancer
Reduced KCNA1 Expression Predicts Prognosis and Metastatic Potential in Papillary Thyroid Carcinoma
Panel: Bioinformatics in Cancer
Role of Counseling and Psychological Support in Improving Fertility among Cancer Patients: A Review Study
Panel: Bioinformatics in Cancer
Role of non-coding RNAs in the regulation of Urothelial bladder cancer stem-ness
Panel: Bioinformatics in Cancer
Selective Detection of HER3-Positive Breast Cancer Cells Using a Novel Affibody-EGFP Biosensor
Panel: Bioinformatics in Cancer
Single Nucleotide Polymorphisms (SNPs) in Lung Cancer: Genetic Risk Factors, Functional Mechanisms, and Clinical Implications
Panel: Bioinformatics in Cancer
siRNA-Mediated Knockdown of BUB1 Impairs Growth and Metastatic Potential in Pheochromocytoma Cells
Panel: Bioinformatics in Cancer
Synthetic Lethality Approaches Using Gene Editing for Targeting Cancer Vulnerabilities
Panel: Bioinformatics in Cancer
Systems Biology Approach Reveals ESR1 and CDK1 Regulatory Axis with miRNA–lncRNA Network as Novel Biomarkers in Uterine Corpus Endometrial Carcinoma
Panel: Bioinformatics in Cancer
Targeted Detection of HER3-Expressing Cancer Cells via a Novel Bioluminescent Affibody
Panel: Bioinformatics in Cancer
Targeting Breast Cancer Stem Cells with CAR-T Cells: A Novel Approach
Panel: Bioinformatics in Cancer
The gut microbiom and colorectal cancer: a new frontier in aging, inflammation and therapeutic responses
Panel: Bioinformatics in Cancer
The Gut Microbiome as a Determinant of Immunotherapy Response in Metastatic Melanoma
Panel: Bioinformatics in Cancer
The Gut Microbiome's Role in Colorectal Cancer Prognosis and Immunotherapy Response
Panel: Bioinformatics in Cancer
The Gut Microbiome's Role in Modulating PD-1/PD-L1 Immunotherapy Efficacy in Melanoma
Panel: Bioinformatics in Cancer
The Human Microbiome in Cancer: Mechanisms, Biomarkers, and Therapeutic Potentials
Panel: Bioinformatics in Cancer
The impact of the gut microbiome on the effectiveness of cancer immunotherapy
Panel: Bioinformatics in Cancer
The interaction of lncRNA and mRNA in Esophageal Squamous Cell Carcinoma
Panel: Bioinformatics in Cancer
The Interplay of HPV Oncoproteins, Tumor Microenvironment, and Extracellular Vesicles in Cervical Cancer Progression
Panel: Bioinformatics in Cancer
The Role of Epigenetics in the Prevention and Treatment of Hereditary Colorectal Cancer through Nutrition and Targeted Therapies.
Panel: Bioinformatics in Cancer
The Role of Gut Microbiome in Colorectal Cancer
Panel: Bioinformatics in Cancer
The Role of SCFAs Derived from Gut Microbiota in Colorectal Cancer Progression; A Systematic Overview
Panel: Bioinformatics in Cancer
The Role of the Human Microbiome in Cancer Development and Therapy Response
Panel: Bioinformatics in Cancer
The Role of the Microbiome in Cancer Prevention and Therapy
Panel: Bioinformatics in Cancer
The Role of the Urinary Microbiome in Prostate Cancer Progression: From Early Detection to Targeted Therapy
Panel: Bioinformatics in Cancer
The suppressive role of the bone marrow microenvironment on natural killer cells’ anti-leukemic activity in acute myeloid leukemia
Panel: Bioinformatics in Cancer
The Tumor Microenvironment and Immunotherapy Response: Challenges and Opportunities in Precision Oncology
Panel: Bioinformatics in Cancer
The Warburg Effect and Cancer Progression: Glycolytic Reprogramming, Epigenetic Modifications, and Therapeutic Perspectives
Panel: Bioinformatics in Cancer
Unraveling the Role of FGFR3 in Melanoma Progression: An Integrated Bioinformatics Approach to mRNA Expression and ceRNA Network Analysis.
Panel: Bioinformatics in Cancer
Unveiling Molecular Mechanisms and Biomarkers for Colitis-Associated Colorectal Cancer in Ulcerative Colitis
Panel: Bioinformatics in Cancer
Using Three Machine Learning Techniques for Predicting Breast Cancer Recurrence
Panel: Bioinformatics in Cancer
Utilizing WGCNA to uncover E2F8 and SPC24 as promising therapeutic targets in breast cancer
Panel: Bioinformatics in Cancer
Wnt/β-catenin Signaling Pathway Mediated by the Gut Microbiome: The Influence of Fusobacterium nucleatum on Colorectal Cancer Progression
Panel: Bioinformatics in Cancer
